MDLN NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Medline Inc. Class A Common Stock · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 39.28 USD
1.4% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -6.2% below the Trend Line and sits at 35.8% of its 52-week range. The latest completed week returned 1.4%, after a -9.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. Options positioning is bullish with 43/100 conviction, while the latest news-sentiment score is 43/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 27 out of 100
Latest Close 39.28 USD 31 Jul 2026
1W Return 1.4% latest completed week
4W Return -9.1% short-term follow-through
12W Return -0.6% quarterly tape
Trend Breadth 0.0% 0 of 33 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.4% Latest completed week; four-week move -9.1%. Indicator stack 0/38 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 36.66% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 43/100 conviction; expected move 12.2%. News sentiment 43/100 56 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -6.2% below the Trend Line and sits at 35.8% of its 52-week range. The latest completed week returned 1.4%, after a -9.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0912-week average 0.07

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -9.1% over four weeks, -0.6% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W1.4%
4W-9.1%
12W-0.6%
26W-11.1%
52W-
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.27Latest activity-pressure read.
Pressure change-90.8%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength8/100Blend of value, momentum, and quality. Underlying universe rank 93; rank 1 is best.
Value17/100Relative valuation strength. Underlying universe rank 84; rank 1 is best.
Quality25/100Profitability and accounting quality. Underlying universe rank 76; rank 1 is best.
Momentum37/100Medium-term price momentum. Underlying universe rank 64; rank 1 is best.
Growth37/100Revenue and earnings growth. Underlying universe rank 64; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework25/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
34.0x
Price divided by trailing earnings.
Price / sales
1.1x
Market value relative to trailing revenue.
EV / EBITDA
18.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
24.0%
Gross profit retained from each unit of revenue.
Operating margin
6.2%
Operating profit retained from revenue.
Free-cash-flow margin
7.5%
Free cash flow generated from revenue.
Return on invested capital
7.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.6%
Cash dividends relative to market value.
Buyback yield
-15.4%
Net share repurchases relative to market value.
Shareholder yield
-13.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

MDLN shows bullish options pressure with a 43/100 conviction score, put-call volume ratio of 0.37, expected move of 12.2%, and Sharemaestro trend signal inactive.

Conviction43/100
Expected move12.2%
Put/call volume0.37
Pressure52
Speculation2
Volatility85
Trend agreement48
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment43/100

Weighted news tone is neutral across 56 relevant articles.

7 positive · 33 neutral · 16 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move12.2%Nearest-chain priced movement where available.
52-week drawdown-22.8%Distance below the 52-week high.
13-week volatility6.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+11.8%Week of 20 Feb.
Worst week-11.7%Week of 8 May.
Latest week+1.4%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains4
Flat weeks0
Modest losses6
Sharp losses9
Recent vol6.7%13-week weekly-return volatility.
Base vol6.3%52-week weekly-return volatility.
Up/down split14/18Count of positive and negative weeks in the 52-week window.
Average skew6.2% / -4.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape26/100

Trend, activity pressure, participation, and risk combine to a 26/100 tape read.

 Indicator analysis10/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.09; No reversal markers Next-Week ExpectancyNegative 36.66%

Next-week expectancy is negative with a 36.66% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors20/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 89 SVQF25/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 546.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options57/100

MDLN shows bullish options pressure with a 43/100 conviction score, put-call volume ratio of 0.37, expected move of 12.2%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 12.2% Sentiment43/100

Weighted news tone is neutral across 56 relevant articles.

Medline's (MDLN) Buy Rating Reiterated at BTIG Research Insiders50/100

No recent insider transaction evidence is stored.

 Earnings3d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202639.28 USD1.4%41.89 USD41.91 USD-0.27-23.4MOff
24 Jul 202638.75 USD-2.6%41.94 USD42.00 USD-0.25-27.8MOff
17 Jul 202639.79 USD-3.0%42.12 USD42.10 USD-0.25-26.9MOff
10 Jul 202641.04 USD-5.0%42.18 USD42.18 USD-0.22-28.1MOff
3 Jul 202643.19 USD11.1%-42.22 USD-0.14-47.9MOff
26 Jun 202638.87 USD8.2%-42.18 USD--38.9MOff
19 Jun 202635.94 USD-1.8%-42.31 USD--49.8MOff
12 Jun 202636.61 USD8.9%-42.55 USD--50.1MOff
5 Jun 202633.61 USD-8.1%-42.79 USD--68.1MOff
29 May 202636.56 USD-1.2%-43.17 USD--72.3MOff
22 May 202637.01 USD2.3%-43.46 USD--83.8MOff
15 May 202636.19 USD-8.4%-43.75 USD--34.6MOff
8 May 202639.52 USD-11.7%-44.11 USD--50.6MOff
1 May 202644.75 USD-0.0%-44.34 USD--20.7MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.